Johnson PJ - Search Results

1

Hepatitis C virus antibodies in chronic active hepatitis: pathogenetic factor or false-positive result?

McFarlane IG, Smith HM, Johnson PJ, Bray GP, Vergani D, Williams R. McFarlane IG, et al. Among authors: johnson pj. Lancet. 1990 Mar 31;335(8692):754-7. doi: 10.1016/0140-6736(90)90870-b. Lancet. 1990. PMID: 1969512

2

Absence of hepatitis C virus in British patients with type 1 autoimmune chronic active hepatitis--a polymerase chain reaction and serological study.

Silva E, Sallie R, Tibbs C, McFarlane I, Johnson P, Williams R. Silva E, et al. J Hepatol. 1993 Sep;19(2):211-5. doi: 10.1016/s0168-8278(05)80573-2. J Hepatol. 1993. PMID: 8301054

3

Antibodies to hepatitis C virus in autoimmune liver disease: evidence for geographical heterogeneity.

Lenzi M, Johnson PJ, McFarlane IG, Ballardini G, Smith HM, McFarlane BM, Bridger C, Vergani D, Bianchi FB, Williams R. Lenzi M, et al. Among authors: johnson pj. Lancet. 1991 Aug 3;338(8762):277-80. doi: 10.1016/0140-6736(91)90418-o. Lancet. 1991. PMID: 1677111

4

Chronic active hepatitis.

Johnson PJ, McFarlane IG. Johnson PJ, et al. Gut. 1991 Sep;Suppl(Suppl):S63-72. doi: 10.1136/gut.32.suppl.s63. Gut. 1991. PMID: 1916471 Free PMC article. Review. No abstract available.

5

The natural course and heterogeneity of autoimmune-type chronic active hepatitis.

Johnson PJ, McFarlane IG, Eddleston AL. Johnson PJ, et al. Semin Liver Dis. 1991 Aug;11(3):187-96. doi: 10.1055/s-2008-1040436. Semin Liver Dis. 1991. PMID: 1925643 Review. No abstract available.

6

Auto-immune features in patients with idiopathic chronic active hepatitis who are seronegative for conventional auto-antibodies.

Johnson PJ, McFarlane IG, McFarlane BM, Williams R. Johnson PJ, et al. J Gastroenterol Hepatol. 1990 May-Jun;5(3):244-51. doi: 10.1111/j.1440-1746.1990.tb01624.x. J Gastroenterol Hepatol. 1990. PMID: 2103405

7

Hepatitis C antibodies and hepatocellular carcinoma: new clues or a false trail?

Johnson PJ, Williams R. Johnson PJ, et al. J Natl Cancer Inst. 1990 Jun 20;82(12):986-7. doi: 10.1093/jnci/82.12.986. J Natl Cancer Inst. 1990. PMID: 2161464 No abstract available.

8

Regulation of insulin-like growth factor II gene expression by hepatitis B virus in hepatocellular carcinoma.

d'Arville CN, Nouri-Aria KT, Johnson P, Williams R. d'Arville CN, et al. Hepatology. 1991 Feb;13(2):310-5. Hepatology. 1991. PMID: 1847351

9

Differential binding of serum glycoproteins to lectins during hepatic regeneration in hepatocellular carcinoma and fulminant hepatic failure.

Du MQ, Hutchinson WL, Johnson PJ, Williams R. Du MQ, et al. Among authors: johnson pj. Clin Sci (Lond). 1990 Jun;78(6):551-5. doi: 10.1042/cs0780551. Clin Sci (Lond). 1990. PMID: 1696194

10

Serum and tissue alpha-L-fucosidase activity in the pre-clinical and clinical stages of hepatocellular carcinoma.

Hutchinson WL, Johnson PJ, Du MQ, Williams R. Hutchinson WL, et al. Among authors: johnson pj. Clin Sci (Lond). 1991 Aug;81(2):177-82. doi: 10.1042/cs0810177. Clin Sci (Lond). 1991. PMID: 1716188

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

962 results

Search Page

Filters